Deafness & Hearing Loss |
|
|
Clinical Trial: Genetic Studies of Tone Deafness
This study is currently recruiting patients.
|
Purpose
This study will examine the hereditary basis of tone deafness by identifying regions of the human genome linked to this condition. Both exceptionally good pitch recognition (perfect pitch) and exceptionally poor pitch recognition (tone deafness) run in families. A better understanding of what causes tone deafness may provide new insights into auditory (hearing) function.
Individuals with two or more family members 15 years of age or older who are tone deaf or have trouble recognizing different melodies may be eligible for this study. Candidates will be screened with a short listening test for pitch and a short written test. Those identified with poor pitch recognition will fill out a brief questionnaire about their family tree and family members (without identifying names) who have trouble recognizing melodies or tones. Individuals with poor pitch recognition will be asked to help contact family members who may be interested in participating.
Members of families with two or more first-degree relatives (parents, grandparents, siblings) who are tone deaf may enroll in the study. They will provide a blood sample (about 2 tablespoons) for genetic studies and may take a 20-minute hearing test using headphones.
| Condition |
|---|
| Healthy Tone Deafness |
MedlinePlus related topics: Aphasia; Hearing Disorders and Deafness
Study Type: Observational
Study Design: Natural History
Official Title: Genetic Studies of Tune Deafness
Expected Total Enrollment: 4000
Study start: July 26, 2000
The primary goal of this study is to identify regions of the genome which show genetic linkage to deficits in pitch recognition. Pitch recognition in subjects will be tested to identify individuals and families with poor pitch recognition, known as tune deafness, defined as the inability to recognize wrong notes in a popular melody. We will undertake a 2-stage process, first a screening to identify probands, and secondly a full family ascertainment and enrollment. Probands and family members will be given additional listening tests to measure aspects of central auditory processing. Family phenotypic data will be used for additional epidemiological studies of tune deafness. Affected and unaffected members of families containing multiple tune deaf individuals will have 20 cc of blood drawn to obtain DNA. These DNA samples will then be genotyped using markers distributed across the human genome, and the genotypic information analyzed to determine which markers show linkage to tune deafness. Genetic linkage is the initial step in the process of positional cloning, and cloning the defective genes which underlie tune deafness is a long term goal of this research.
Eligibility
Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Subject is 15 years old or older.
Subject or member of subject's family has a score of 21 or less on the Distorted Tunes Test.
Subject has score of 24 or less on the 5 minute Hearing Test.
Subject is not cognitively impaired, or using psychoactive medication.
EXCLUSION CRITERIA:
Hearing impaired individuals, as first estimated by a score of 25 or greater on the American Academy of Otolaryngology's 5 Minute Hearing Test, or subsequently by audiological exam.
Cognitively impaired individuals.
Family members in families where only one person exhibits tune deafness.
Individuals currently using psychoactive medication.
Location and Contact Information
Maryland
National Institute on Deafness and Other Communication Disorders (NIDCD), 9000 Rockville Pike, Bethesda, Maryland, 20892, United States; Recruiting
TTY 1-866-411-1010
More Information
Detailed Web Page
Publications
Profita J, Bidder TG. Perfect pitch. Am J Med Genet. 1988 Apr;29(4):763-71.
Wightman FL, Green DM. The perception of pitch. Am Sci. 1974 Mar-Apr;62(2):208-15. No abstract available.
Baharloo S, Johnston PA, Service SK, Gitschier J, Freimer NB. Absolute pitch: an approach for identification of genetic and nongenetic components. Am J Hum Genet. 1998 Feb;62(2):224-31.
Record last reviewed: July 30, 2004
Last Updated: November 23, 2004
Record first received: July 28, 2000
ClinicalTrials.gov Identifier: NCT00006076
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


